Effect of vaginal administration of misoprostol before intrauterine contraceptive insertion following previous insertion failure: A double blind RCT

Human Reproduction

Volumn 30, Issue 8, 2015, Pages 1861-1866

  Bahamondes, M Valeria ^a   Espejo Arce, Ximena ^a   Bahamondes, Luis ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

copper intrauterine device; insertion failure; intrauterine contraceptives; levonorgestrel releasing intrauterine system; misoprostol

Indexed keywords

MISOPROSTOL; PLACEBO; CONTRACEPTIVE AGENT; LEVONORGESTREL;

ADULT; ARTICLE; CESAREAN SECTION; CONTROLLED STUDY; COPPER INTRAUTERINE DEVICE; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; INTRAUTERINE CONTRACEPTIVE DEVICE; LEVONORGESTREL RELEASING INTRAUTERINE SYSTEM; MAJOR CLINICAL STUDY; MULTIPLE REGRESSION; NULLIGRAVIDA; POPULATION RISK; PREGNANCY; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; TREATMENT FAILURE; TREATMENT OUTCOME; INTRAVAGINAL DRUG ADMINISTRATION; RETREATMENT;

ADMINISTRATION, INTRAVAGINAL; ADULT; CONTRACEPTIVE AGENTS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INTRAUTERINE DEVICES, MEDICATED; LEVONORGESTREL; MISOPROSTOL; RETREATMENT;

EID: 84939636079     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/dev137     Document Type: Article

References (21)

1. Bahamondes MV, Hidalgo MM, Bahamondes L, Monteiro I. Ease of insertion and clinical performance of the levonorgestrel-releasing intrauterine system in nulligravidas. Contraception 2011;84:e11-e16.
2. Bahamondes L, Bottura BF, Bahamondes MV, Gonçalves MP, Correia VM, Espejo-Arce X, Sousa MH, Monteiro I, Fernandes A. Estimated disability-adjusted life years averted by long-term provision of long acting contraceptive methods in a Brazilian clinic. Hum Reprod 2014a;29:2163-2170.
3. Bahamondes L, Mansour D, Fiala C, Kaunitz AM, Gemzell-Danielsson K. Practical advice for avoidance of pain associated with insertion of intrauterine contraceptives. J Fam Plann Reprod Health Care 2014b;40:54-60.
4. Berenson AB, Tan A, Hirth JM, Wilkinson GS. Complications and continuation of intrauterine device use among commercially insured teenagers. Obstet Gynecol 2013;121:951-958.
5. Dijkhuizen K, Dekkers OM, Holleboom CA, de Groot CJ, Hellebrekers BW, van Roosmalen GJ, Janssen CA, Helmerhorst FM. Vaginal misoprostol prior to insertion of an intrauterine device: an RCT. Hum Reprod 2011;26:323-329.
6. Edelman AB, Schaefer E, Olson A, Van Houten L, Bednarek P, Leclair C, Jensen JT. Effects of prophylactic misoprostol administration prior to intrauterine device insertion in nulliparous women. Contraception 2011;84:234-239.
7. ESHRE Capri Workshop Group. Intrauterine devices and intrauterine systems. Hum Reprod Update 2008;14:197-208.
8. Espey E, Singh RH, Leeman L, Ogburn T, Fowler K, Greene H. Misoprostol for intrauterine device insertion in nulliparous women: a randomized controlled trial. Am J Obstet Gynecol 2014;210:208.e1-5.
9. Ferreira JM, Nunes FR, Modesto W, Gonçalves MP, Bahamondes L. Reasons for Brazilian women to switch from different contraceptives to long-acting reversible contraceptives. Contraception 2014;89:17-21.
10. Gemzell-Danielsson K, Mansour D, Fiala C, Kaunitz AM, Bahamondes L. Management of pain associated with the insertion of intrauterine contraceptives. Hum Reprod Update 2013;19:419-427.
11. Heikinheimo O, Inki P, Kunz M, Parmhed S, Anttila AM, Olsson SE, Hurskainen R, Gemzell-Danielsson K. Double-blind, randomized, placebo-controlled study on the effect of misoprostol on ease of consecutive insertion of the levonorgestrel-releasing intrauterine system. Contraception 2010;81:481-486.
12. Ibrahim ZM, Sayed Ahmed WA. Sublingual misoprostol prior to insertion of a T380A intrauterine device in women with no previous vaginal delivery. Eur J Contracept Reprod Health Care 2013;18:300-308.
13. Lathrop E, Haddad L, McWhorter CP, Goedken P. Self-administration of misoprostol prior to intrauterine device insertion among nulliparous women: a randomized controlled trial. Contraception 2013;88:725-729.
14. Li YT, Kuo TC, Kuan LC, Chu YC. Cervical softening with vaginal misoprostol before intrauterine device insertion. Int J Gynaecol Obstet 2005;89:67-68.
15. Marions L, Lövkvist L, Taube A, Johansson M, Dalvik H, Øverlie I. Use of the levonorgestrel releasing-intrauterine system in nulliparous women: a non-interventional study in Sweden. Eur J Contracept Reprod Health Care 2011;16:126-134.
16. Ofili-Yebovi D, Ben-Nagi J, Sawyer E, Yazbek J, Lee C, Gonzalez J, Jurkovic D. Deficient lower-segment Cesarean section scars: prevalence and risk factors. Ultrasound Obstet Gynecol 2008;31:72-77.
17. Saav I, Aronsson A, Marions L, Stephansson O, Gemzell-Danielsson K. Cervical priming with sublingual misoprostol prior to insertion of an intrauterine device in nulliparous women: a randomized controlled trial. Hum Reprod 2007;22:2647-2652.
18. Scavuzzi A, Souza ASR, Costa AAR, Amorim MMR. Misoprostol prior to inserting an intrauterine device in nulligravidas: a randomized clinical trial. Hum Reprod 2013;28:2118-2125.
19. Schaefer E, Van Houten L, Olson A, Leclair C, Bednarek PH, Edelman A. Prophylactic misoprostol prior to IUD insertion in nulliparous women. Contraception 2010;82:188.
20. Ward K, Jacobson JC, Turok DK, Murphy PA. A survey of provider experience with misoprostol to facilitate intrauterine device insertion in nulliparous women. Contraception 2011;84:594-599.
21. Winner B, Peipert JF, Zhao Q, Buckel C, Madden T, Allsworth JE, Secura GM. Effectiveness of long-acting reversible contraception. N Engl J Med 2012;366:1998-2007.